The Discovery of Sotorasib (AMG 510): First-in-Class Investigational Covalent Inhibitor of KRAS G12C - American Chemical Society
acs.org
The Discovery of Sotorasib (AMG 510): First-in-Class Investigational Covalent Inhibitor of KRAS G12C - American Chemical Society
American Chemical Society: Chemistry for Life.
Dec 7, 2022
Related Products
Sotorasib Keychain
Sotorasib Book
Sotorasib Mug
#Sotorasib Cancer Treatment
Sotorasib is approved in the United States to treat KRAS p.G12C–mutated non–small-cell lung cancer. Its efficacy and safety in KRAS p.G12C–mutated pancreatic cancer have been unknown. New research findings are summarized in a short video. https://nej.md/3GfOXNp | The New England Journal of Medicine
Sotorasib is approved in the United States to treat KRAS p.G12C–mutated non–small-cell lung cancer. Its efficacy and safety in KRAS p.G12C–mutated pancreatic cancer have been unknown. New research findings are summarized in a short video. https://nej.md/3GfOXNp | The New England Journal of Medicine
FacebookJan 4, 2023
46K views · 891 reactions | At Hope4Cancer™ Treatment Centers, we know that there is more to healing than just the physical body. Learn More Today! | Hope4Cancer Treatment Centers | Facebook
46K views · 891 reactions | At Hope4Cancer™ Treatment Centers, we know that there is more to healing than just the physical body. Learn More Today! | Hope4Cancer Treatment Centers | Facebook
Facebook2 weeks ago
Top videos
NSCLC: Sotorasib in Practice | OncLive
NSCLC: Sotorasib in Practice | OncLive
onclive.com
3 weeks ago
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (ROS1 ), Sotorasib (KRAS G12C), Zipalertinib (EGFR exon 20), Sevabertinib/Zongertinib (HER2m)
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (ROS1 ), Sotorasib (KRAS G12C), Zipalertinib (EGFR exon 20), Sevabertinib/Zongertinib (HER2m)
vumedi.com
2 months ago
Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotorasib
Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotorasib
made-in-china.com
1 month ago
Sotorasib Clinical Trials
1.1K views · 22 reactions | Happy Clinical Trials Day! “Your work is never done, but it always makes a difference. That’s why today is all about you. Because for you, every day is all about the rest of us.” | ACRP - Association of Clinical Research Professionals | Facebook
1:47
1.1K views · 22 reactions | Happy Clinical Trials Day! “Your work is never done, but it always makes a difference. That’s why today is all about you. Because for you, every day is all about the rest of us.” | ACRP - Association of Clinical Research Professionals | Facebook
FacebookACRP - Association of
2K views2 weeks ago
1.1K views · 15 reactions | “2020 may be the most important opportunity in decades to talk about clinical trials.” Let’s make some noise tomorrow! Thanks to Dartmouth-Hitchcock for supporting Clinical Trials Day > clinicaltrialsday.org | ACRP - Association of Clinical Research Professionals | Facebook
0:56
1.1K views · 15 reactions | “2020 may be the most important opportunity in decades to talk about clinical trials.” Let’s make some noise tomorrow! Thanks to Dartmouth-Hitchcock for supporting Clinical Trials Day > clinicaltrialsday.org | ACRP - Association of Clinical Research Professionals | Facebook
FacebookACRP - Association of
2K views2 weeks ago
The only existing treatment for the symptoms of celiac disease is strict adherence to a gluten-free diet. We are researching an investigational study drug for celiac disease. See if you may qualify for our study today. | Trialbee Clinical Trials | Facebook
0:08
The only existing treatment for the symptoms of celiac disease is strict adherence to a gluten-free diet. We are researching an investigational study drug for celiac disease. See if you may qualify for our study today. | Trialbee Clinical Trials | Facebook
FacebookTrialbee Clinical Trials
7.2K views2 weeks ago
NSCLC: Sotorasib in Practice | OncLive
NSCLC: Sotorasib in Practice | OncLive
3 weeks ago
onclive.com
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (ROS1 ), Sotorasib (KRAS G12C), Zipalertinib (EGFR exon 20), Sevabertinib/Zongertinib (HER2m)
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (R…
2 months ago
vumedi.com
Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotorasib
Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotorasib
1 month ago
made-in-china.com
Tumore dei polmoni, efficace la pillola mirata Sotorasib: lo studio
1:38
Tumore dei polmoni, efficace la pillola mirata Sotorasib: lo studio
May 10, 2022
sky.it
Tumore al polmone, rimborsato in Italia Sotorasib
Tumore al polmone, rimborsato in Italia Sotorasib
Jun 28, 2024
askanews.it
Tumore al polmone, rimborsato in Italia Sotorasib
Tumore al polmone, rimborsato in Italia Sotorasib
Jul 1, 2024
Il Sole 24 ORE
Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Efficacy and Safety of Crizotinib, Sotorasib Data in KRAS G12C NSCLC
Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Effica…
2 months ago
vumedi.com
Sotorasib funziona nel tumore del polmone NSCLC avanzato | Milano…
Mar 2, 2021
milanofinanza.it
2:11
Sotorasib is approved in the United States to treat KRAS p.G12C–mut…
2.5K viewsJan 4, 2023
FacebookThe New England Journal of Medicine
Sotorasib: New drug that destroys lung cancer
Nov 4, 2021
news4jax.com
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mu…
11 months ago
onclive.com
Dr Goldberg on the Investigation of VIC-1911 With/Without Sotorasib i…
Jul 21, 2023
onclive.com
Dr. Dy on the Use of Sotorasib in KRAS G12C–Mutated NSCLC
Apr 10, 2022
onclive.com
Dr Strickler on the Efficacy of Sotorasib Plus Panitumumab/Che…
6 months ago
onclive.com
Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for …
10 months ago
onclive.com
5:48
Oncogene-addicted NSCLC
33 views3 months ago
YouTubeCOR2ED The Heart of Medical Education
11:24
Dr. Consuelo Díaz | Use of Sotorasib with Panitumumab in Patients wit…
3 views2 months ago
YouTubeVOZ de LÍDERES
2:46
Revolutionary Cancer Cure: Targeting Undruggable KRAS Mut…
1 month ago
YouTubeUniversal Moments
索托拉西布(Sotorasib、LUMAKRAS)药品信息展示【海鸥 …
2 weeks ago
sohu
Sotorasib,FDA,Lumakras amgen 510,non-small cell lung cancer
2.5K viewsJun 21, 2021
YouTubePicFun Medicosis
Antibody Drug Conjugate Sacituzumab Govitecan Shows Eff…
643 viewsMay 5, 2020
YouTubeTargeted Oncology
Sotorasib – Mechanism of Action and Synthesis
2.6K viewsSep 9, 2023
YouTubeOrganic Chemistry with Lluís Llorens Palomo
Tumore al polmone, rimborsato in Italia Sotorasib
Jun 28, 2024
iltempo.it
3:03
ESMO 2020 Highlights on durability of clinical benefit and biomarkers …
1.5K viewsSep 20, 2020
YouTubeEuropean Society for Medical Oncology (ESMO)
Sotorasib: New Drug Destroys Lung Cancer
9 months ago
MSN
#ESMO22 Highlights on Sotorasib in NSCLC with KRAS G12C mutation…
2.8K viewsSep 12, 2022
YouTubeEuropean Society for Medical Oncology (ESMO)
March 9, 2023 Meeting of the Oncologic Drugs Advisory Commi…
11.6K viewsMar 9, 2023
YouTubeU.S. Food and Drug Administration
ESMO22 -LBA10 - Sotorasib vs docetaxel for previously treated N…
227 viewsSep 13, 2022
YouTubeOncoletter
Disappointing Sotorasib Results: How to Move Forward
377 viewsApr 6, 2024
YouTubeMedscape
See more videos
Static thumbnail place holder